Silexion Therapeutics Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 05/15/2026 | 20.93 K | $26.79 K | 71.45% | 0.65% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 11.66 K | $14.92 K | 100.00% | 0.36% |
| MONTAG A & ASSOCIATES INC | 04/29/2026 | 3.00 K | $3.84 K | 0.00% | 0.09% |
| UBS GROUP AG | 05/05/2026 | 517 | $662 | -69.43% | 0.02% |
| PFLUG KOORY, LLC | 04/22/2026 | 333 | $426 | 0.00% | 0.01% |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 26 | $32 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 20 | $26 | -98.11% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Silexion Therapeutics Corp institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of Silexion Therapeutics Corp. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 20,926
TWO SIGMA SECURITIES, LLC: 11,657
MONTAG A & ASSOCIATES INC: 3,000
UBS Group AG: 517
Pflug Koory, LLC: 333
JONES FINANCIAL COMPANIES LLLP: 26
1.13% of Silexion Therapeutics Corp stock is owned by institutional investors.
Institutional investors have bought a total of 36.48 K shares in the last 24 months. This purchase volume represents approximately $71.50 K in transactions.